Clinical Report: Ovine Forestomach Matrix Implant for Perianal Fistula Surgery

Overview

This retrospective case series evaluated the use of ovine forestomach matrix (OFM) as a minimally invasive implant for treating cryptoglandular perianal fistulas. The study demonstrated that OFM implants can facilitate fistula closure with minimal postoperative complications and may reduce the need for more invasive surgical procedures.

Background

Cryptoglandular perianal fistulas present a surgical challenge due to high recurrence rates and risks of sphincter injury. Traditional invasive treatments like LIFT or mucosal advancement flaps offer better efficacy but carry higher complication risks. Less invasive methods, including fibrin glue and biomaterial plugs, have lower risks but often reduced efficacy. OFM, a decellularized extracellular matrix biomaterial, has shown promise in contaminated and inflamed wound healing and was investigated here as a novel implant for fistula closure.

Data Highlights

Key Findings

• OFM implants were successfully used in 14 consecutive patients with cryptoglandular perianal fistulas.
• All patients underwent a minimally invasive procedure involving seton placement followed by OFM implant insertion.
• The OFM device was prepared by hydrating and rolling into a cylindrical shape matching fistula dimensions.
• Primary endpoint was complete fistula healing at 8 weeks postoperatively.
• Patients with gross infection or persistent purulent discharge were excluded from OFM implantation.
• Follow-up at multiple intervals allowed monitoring of healing, recurrence, and complications.

Clinical Implications

The use of OFM as a perianal fistula implant offers a promising minimally invasive alternative to traditional surgical methods, potentially reducing postoperative complications and preserving sphincter function. This approach may be particularly advantageous for patients unsuitable for more invasive procedures or those at higher risk of infection. Further studies could validate efficacy and long-term outcomes.

Conclusion

OFM implants represent a novel, biologically compatible option for perianal fistula closure that balances efficacy with a favorable safety profile. This initial case series supports further investigation into OFM as a standard treatment modality.

References

1. LifeBridge Health Institutional Review Board -- Study Protocol and Ethical Oversight
2. Aroa Biosurgery Limited -- Myriad Matrix Soft Tissue Bioscaffold™
3. Clinical Literature on PF Surgical Management -- Background and Comparative Techniques